Additionally, HCC tumor-derived alpha-fetoprotein (AFP) has been shown to disrupt DC metabolism by inhibiting mTORC1 signaling, resulting in defective oxidative phosphorylation, impaired mitochondrial integrity, and a diminished capacity to stimulate T cells in vitro [381]. The gene discussed is AFP; the disease is hepatocellular carcinoma.